IP Library Patent Application 12104515
Patent Application
App. No. 12/104,515

CURRENT DENSITY DETECTION AND CONTROL SYSTEM AND METHOD FOR AN ELECTROKINETIC DELIVERY OF MEDICAMENTS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/104,515
Abstract

An apparatus to monitor current density in the application of medicament to a treatment site of a mammalian user of a electrokinetic device including: an applicator cartridge including an active electrode, a matrix carrying a medicament or a medicament and an electrically conductive carrier; a device including an electrical power source connectable to the active electrode, a counter electrode, and an electronic circuit configured to control the application of electrical current through the active electrode to establish a conductive path extending from the power source, through the active electrode, matrix, the treatment site, the user and the counter electrode electrically connected to the power source, and an array of contacts monitoring current density flowing through the matrix and to the treatment site, wherein the array of sensors are arranged monitor the current density at various locations of the matrix and a contact area between the matrix and skin above the treatment site.

Claims (32)

1 . An apparatus to monitor current density in the application of medicament to a treatment site of a mammalian user of a electrokinetic device, the apparatus comprising:

an applicator cartridge including an active electrode, a matrix carrying a medicament or a medicament and an electrically conductive carrier;

a device including an electrical power source connectable to the active electrode, a counter electrode, and an electronic circuit configured to control the application of electrical current through the active electrode to establish a conductive path extending from the power source, through the active electrode, matrix, the treatment site, the user and the counter electrode electrically connected to the power source, and

an array of contacts monitoring current density flowing through the matrix and to the treatment site, wherein the array of sensors are arranged monitor the current density at various locations of the matrix and a contact area between the matrix and skin above the treatment site.

2 . An apparatus as in claim 1 wherein the array of contacts are an array of conductive pads arranged on a periphery of the matrix.

3 . An apparatus as in claim 2 wherein the periphery of the matrix is cylindrical sidewall of the matrix and the array of contacts is mounted on the cartridge to abut the cylindrical sidewall of the matrix.

4 . An apparatus as in claim 1 wherein the active electrode is an array of active electrodes spatially arranged to contact various locations of the surface and the array of contacts includes electrical contacts for each of the active electrodes in the array.

5 . An apparatus as in claim 4 wherein the array of active electrodes is arranged on an inside surface of the cartridge and the inside surface of the cartridge abuts a surface of the matrix opposite to a surface of the matrix which contacts skin over the treatment site.

6 . An apparatus as in claim 1 wherein the further comprising an electronic circuit coupled to the array of contacts, wherein the electronic circuit compares a voltage potentials at least two of the contacts in the array and generates an alarm if a difference of the voltage potentials of the at least two contacts exceeds a predetermined threshold limit.

7 . An apparatus as in claim 1 wherein the further comprising an electronic circuit coupled to the array of contacts, wherein the electronic circuit compares a voltage potential between at least two of the contacts in the array and the circuit reduces current applied to the active electrode if a difference of the voltage potentials of the at least two contacts exceeds a predetermined threshold limit.

8 . An apparatus as in claim 7 wherein the reduction in the current is a reduction to zero current.

9 . An apparatus to monitor current density in the application of medicament to a treatment site of a mammalian user of a electrokinetic device, the apparatus comprising:

an applicator cartridge including an active electrode, a matrix carrying a medicament or a medicament and an electrically conductive carrier;

a device including an electrical power source connectable to the active electrode and a counter electrode, and an electronic circuit configured to control electrical current through the active electrode to establish a conductive path extending from the power source, through the active electrode, matrix, the treatment site, and the counter electrode electrically connected to the power source;

an array of contacts monitoring current at various locations of the matrix, and

a current control circuit adjusting the current through the matrix if the voltage potential on one contact of the array of contacts is substantially different than a voltage potential of at least one of the other contacts in the array of contacts.

10 . An apparatus as in claim 9 wherein the current control circuit includes at least one operational amplifier comparing the voltage potentials of at least two of the contacts in the array of contacts.

11 . An apparatus as in claim 9 wherein the current control circuit includes at least two operational amplifiers each comparing the voltage potentials of at least two of the contacts in the array of contacts, and another operational amplifier monitoring outputs form the at least two operational amplifiers.

12 . An apparatus as in claim 9 wherein the current control circuit includes a field effect transistor in series with each of the contacts in the array of contacts, and the field effect transistors each having a gain connected to a common voltage potential.

13 . An apparatus as in claim 9 wherein each of the contacts in the array of contacts has a conductive connection to a respective active electrode in an array of active electrodes.

14 . A method to monitor electrical current while applying medicament to a treatment site of a mammalian user of a electrokinetic device, the method comprising:

placing over the treatment site and on skin of the user, a matrix carrying a medicament or a medicament with an electrically conductive carrier;

applying electrical power to an active electrode electrically coupled to the matrix to establish a current flow from the active electrode, through the matrix and skin and to the treatment site;

monitoring the current flow at a plurality of locations of the matrix;

determining if the current flow through one location of the plurality of locations is substantially different that the current flow through another location of the plurality of locations, and

reducing the current if there is a substantial difference in the current flow.

15 . A method as in claim 14 wherein the current flow is monitored at a plurality of contact pads arranged around a periphery of the matrix.

16 . A method as in claim 14 wherein the current flow is monitored at a plurality of contacts each coupled to one electrode in an array of the active electrodes.

17 . A method as in claim 14 wherein the current flow is monitored by determining a voltage potential at each of the locations on the matrix.

18 . A method as in claim 14 wherein reducing the current includes shutting off the current.

19 . A method as in claim 14 wherein the active electrode is an array of active electrodes and reducing the current includes reducing current to one of the active electrodes in the array below the current applied to other active electrodes in the array.

20 . A method as in claim 14 wherein reducing the current is performed by field effect transistors (FETs) each having gains at a common voltage potential.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2011
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: NITRIC BIOTHERAPEUTICS, INC.
Reel/Frame 026097/0089 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2009
From: TRANSPORT PHARMACEUTICALS, INC.
To: NITRIC BIOTHERAPEUTICS, INC.
Reel/Frame 023456/0269 →
SECURITY AGREEMENT Recorded Nov 3, 2009
From: NITRIC BIOTHERAPEUTICS, INC.
To: TRANSPORT PHARMACEUTICALS, INC.
Reel/Frame 023456/0433 →
ASSIGNMENT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Nov 3, 2009
From: TRANSPORT PHARMACEUTICALS, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 023456/0493 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2008
From: BARSNESS, MICHAEL S.; DOHERTY, EDWARD J.
To: TRANSPORT PHARMACEUTICALS, INC.
Reel/Frame 020815/0407 →